ProjectPOLARIS – Addendum zu interventionellen Studie
Basic data
Acronym:
POLARIS
Title:
Addendum zu interventionellen Studie
Duration:
01/12/2016 to 31/08/2018
Abstract / short description:
Addendum No. 2 zur Studie: Multicenter, randomized, open-label, efficacy assessor-blinded, active comparator-controlled phase 3b study to compare the efficacy of guselkumab to fumaric acid esters (Fumaderm initial/Fumaderm) for adult patients with moderate to severe plaque psoriasis who are candidates for and naive to systemic treatment.
Keywords:
dermatology
Dermatologie
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Neuss, Nordrhein-Westfalen, Germany